# Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol Foam

> **NCT02800824** · PHASE1 · COMPLETED · sponsor: **Padagis LLC**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Budesonide
- **DRUG:** Uceris

## Key facts

- **NCT ID:** NCT02800824
- **Lead sponsor:** Padagis LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02800824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02800824, "Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol Foam". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02800824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*